Financed by EU fonds
Laboratory equipment
Laboratory technician working with microscope

20

Years of Research Experience

Innovative Solutions

Welcome to Genera Research

We are the trusted experts

Genera Research Ltd. is a clinical-stage biotechnology company founded in Croatia and is developing recombinant human Bone Morphogenetic Protein (BMP) based products for use in the tissue regeneration and treatment of orthopaedic, spinal, and dental reconstructive procedures.
  • Bone Morphogenetic Proteins
  • Translational and Clinical Research
  • Drug development
Research Experts

Meet Our Management Team

Dora Adanić

COO & CFO

Tamara Božić

Quality Chief
Muhamed Catic

Muhamed Čatić

Founding Advisor
Roland Zonai

Roland Zonai

Business Development Director / CBO
https://www.linkedin.com/posts/osteogrow-medtechinnovator-mtiradarforum-ugcPost-7447550813855551489-oocy?utm_source=share&utm_medium=member_desktop&rcm=ACoAADHPMSYBkg6DAZ5mY3UJoZquz792V6vhrvQ
84,
2026

MedTech Innovator Radar Forum 2026

Genera Research Ltd. is participating in the MedTech Innovator Radar Forum 2026, held from April 7–9 in Manhattan Beach, California. The Radar Forum represents a central part of the MedTech Innovator evaluation process, where selected companies present their technologies through live pitch sessions and engage directly with investors, industry leaders, and clinical experts. Insights from these sessions contribute to the final selection of companies for the MedTech Innovator accelerator. MedTech Innovator is recognized as the world’s largest accelerator for medical device, digital health, and diagnostic companies, focused on advancing innovations that improve patient outcomes and transform healthcare globally. Participation in the Radar Forum places Genera Research among a select group of companies developing high-impact medical technologies. On the first day of the event, Genera Research presented its technology, OSTEOGROW-C, in front of four panels of expert judges. The sessions included direct discussions and feedback from investors, strategics, and key decision-makers in the medtech field. The Forum continues over the following days with additional meetings and networking opportunities, providing a valuable platform for further discussions and potential collaborations.


https://eic.ec.europa.eu/events/eic-info-day-zagreb-croatia-2026-02-18_en
202,
2026

EIC Info Day in Zagreb, Croatia

Croatian Science Foundation (HRZZ), Croatian Agency for SMEs, Innovation and Investment (HAMAG-BICRO), and the Ministry of Science, Education and Youth (MZOM) organised the National Info Day of the Horizon Europe Programme - European Innovation Council (EIC). At the EIC Info Day held in Zagreb on 18 February 2026, Dora Adanić took part as a speaker in a discussion focused on the EIC Accelerator programme and its highly competitive evaluation process. During the session, she shared practical insights on what makes a proposal stand out, the importance of building a strong team alongside breakthrough technology, and how companies should prepare 6–12 months ahead of submission. She also addressed key topics such as risk management, scale-up strategy, competition, and the value of coaching and external feedback when developing a successful application. The discussion concluded with concrete advice for future applicants aiming to secure EIC Accelerator support.